Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Emily Zadvorny

Concepts (62)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Students, Pharmacy
3
2019
100
0.550
Why?
Pharmacists
4
2019
237
0.520
Why?
Cardiac Rehabilitation
1
2015
33
0.480
Why?
Education, Pharmacy
3
2019
128
0.460
Why?
Smoking Prevention
1
2015
156
0.460
Why?
Tobacco Use Disorder
1
2015
235
0.410
Why?
Nicotine
1
2015
266
0.410
Why?
Counseling
1
2015
347
0.400
Why?
Smoking Cessation
1
2015
377
0.370
Why?
Community Pharmacy Services
2
2007
45
0.340
Why?
Preceptorship
2
2019
63
0.300
Why?
Educational Measurement
2
2019
262
0.270
Why?
Vaccination
1
2007
1210
0.160
Why?
Coronary Artery Disease
3
2010
607
0.150
Why?
Schools, Pharmacy
2
2007
52
0.140
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2007
180
0.130
Why?
Cholesterol, LDL
2
2010
309
0.090
Why?
Hypolipidemic Agents
1
2010
87
0.080
Why?
Lisinopril
1
2007
14
0.070
Why?
Accreditation
1
2007
78
0.070
Why?
Pharmacy Service, Hospital
1
2007
84
0.070
Why?
Antihypertensive Agents
2
2007
432
0.070
Why?
Prospective Studies
2
2015
6276
0.060
Why?
Immunization Programs
1
2007
207
0.060
Why?
Time Factors
1
2015
6171
0.060
Why?
Cardiovascular Diseases
1
2015
1729
0.060
Why?
Colorado
3
2007
4116
0.050
Why?
Aged
4
2015
19294
0.050
Why?
Clinical Competence
1
2007
912
0.040
Why?
Blood Pressure
1
2006
1539
0.040
Why?
Humans
9
2019
115741
0.040
Why?
Diabetes Mellitus
1
2007
908
0.040
Why?
Middle Aged
3
2015
27069
0.040
Why?
Patient Care
1
2019
103
0.040
Why?
Hypertension
1
2006
1064
0.040
Why?
Medication Therapy Management
1
2019
67
0.040
Why?
Program Development
1
2019
350
0.040
Why?
Male
4
2015
56050
0.030
Why?
Pilot Projects
1
2019
1384
0.030
Why?
Female
4
2015
60018
0.030
Why?
Curriculum
1
2019
855
0.030
Why?
Diabetes Mellitus, Type 2
1
2006
2098
0.030
Why?
Retrospective Studies
3
2019
12633
0.030
Why?
Ezetimibe
1
2010
24
0.020
Why?
Azetidines
1
2010
31
0.020
Why?
Secondary Prevention
1
2010
223
0.020
Why?
Drug Evaluation
1
2007
79
0.020
Why?
Health Maintenance Organizations
1
2007
96
0.020
Why?
Cardiotonic Agents
1
2007
119
0.020
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2010
373
0.020
Why?
Drug Monitoring
1
2006
184
0.020
Why?
Comorbidity
1
2007
1473
0.010
Why?
Ambulatory Care
1
2006
479
0.010
Why?
Practice Guidelines as Topic
1
2010
1405
0.010
Why?
Cross-Sectional Studies
1
2010
4448
0.010
Why?
Aged, 80 and over
1
2010
6423
0.010
Why?
Follow-Up Studies
1
2006
4442
0.010
Why?
Risk Factors
1
2010
8702
0.010
Why?
Cohort Studies
1
2006
4949
0.010
Why?
Young Adult
1
2010
10518
0.010
Why?
Treatment Outcome
1
2006
9162
0.010
Why?
Adult
1
2007
30789
0.000
Why?
Zadvorny's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)